Accuracy of Index Lymph Node Pathology in Predicting Overall Response to Neoadjuvant Immunotherapy for Clinical Stage III Melanoma: Results From the Prospective
For patients with clinical stage III melanoma, a potentially surgically curable disease, neoadjuvant immunotherapy improves event-free survival. Substantial pathologic complete response (pCR) rates in the affected nodal basin have raised interest in response-directed care includi
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.